Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,300 | -23,770 | -25,550 | -13,360 | -4,660 |
| Depreciation Amortization | 760 | 2,260 | 1,730 | 1,060 | 500 |
| Other Working Capital | 2,570 | -25,630 | 0 | 9,200 | 1,800 |
| Other Operating Activity | -7,650 | 26,670 | 16,620 | -5,640 | -1,690 |
| Operating Cash Flow | $-9,620 | $-20,470 | $-7,200 | $-8,740 | $-4,050 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,180 | -11,740 | -7,980 | -3,350 | -1,420 |
| Other Investing Activity | 60 | 240 | 0 | 120 | 70 |
| Investing Cash Flow | $-9,120 | $-11,500 | $-7,980 | $-3,230 | $-1,350 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 100 | 233,980 | 245,030 | 106,210 | 420 |
| Financing Cash Flow | $100 | $233,980 | $245,030 | $106,210 | $420 |
| Exchange Rate Effect | 6,330 | 3,040 | -7,150 | 1,680 | 330 |
| Beginning Cash Position | 256,220 | 61,740 | 65,110 | 63,470 | 63,090 |
| End Cash Position | 243,920 | 266,780 | 287,820 | 159,380 | 58,440 |
| Net Cash Flow | $-12,300 | $205,040 | $222,700 | $95,910 | $-4,640 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,620 | -20,470 | -7,200 | -8,740 | -4,050 |
| Free Cash Flow | -9,620 | -20,470 | -7,200 | -8,740 | -4,050 |